We are working towards a future where late-stage diseases are a rarity by developing products to help detect them at their earliest stages.

Learn More

Software purpose-built to increase compliance, increase revenue, and improve patient outcomes.

Our AI-suite of compliance, improvement software and adjunctive aids are designed to solve complex problems with comprehensive solutions across the entire care continuum.

We have developed a state-of-the-art artificial intelligence (AI) suite to improve:

Breast cancer screening compliance rates

Breast cancer risk and breast density accuracy, consistency, and workflow

Clinic operations to ensure patients receive timely and compassionate care

Capacity utilization and forecasting

The patient experience through a mobile app that gives the consumer access to their medical images with the ability to share instantly

ACT

AI-powered software solution designed to dramatically increase breast cancer screening compliance.

Learn More

WRDensity

Creating uniformity of density assessments at a practice level.

Learn More

WRRisk

An end-to-end digital solution for breast cancer risk assessment.

Learn More

Find out how our products can help your business increase compliance, increase revenue and improve outcomes.

Request a Demo

Using some of the world's largest radiology data sets, our team of experts have developed a suite of AI-powered tools that enable dramatic change across the full testing lifecycle.

“A customer testimonial goes here. A physician or user testimonial goes here. A physician or user testimonial goes here.A physician or user testimonial goes here. A physician or user testimonial goes here. A physician or user testimonial goes here.”

— Attribution

Our products have made an impact at more than 300 breast health centers across the country.

ACT has driven a
20% improvement in compliance YOY for our largest customer.¹

WRDensity has demonstrated an 82.2% accuracy (BI-RADS A, B, C, D) compared to inter-radiologist agreement at just 67.4%.²

Our Research

We are dedicated to advancing the vanguard of training, validation, and application of AI to benefit patients, radiologists, clinic operators, and payors; take a moment to review some of our work.

News

Whiterabbit.ai: Why We Invested

News

RadNet and Whiterabbit.ai Form a Comprehensive Partnership to Address Mammography Compliance and Improved Diagnostics for Breast Cancer

News

Follow the Whiterabbit: AI developer exits stealth mode with FDA OK for breast cancer screening tool

Stay in touch

Subscribe to our email list to keep up with our work.

Thank you! Your submission has been received!

Oops! Something went wrong while submitting the form.

Footnotes

1 Whiterabbit data on file

2 From “A Multisite Study of a Breast Density Deep Learning Model for Full-Field Mammography and Synthetic Mammography” published in Radiology: Artificial Intelligence

We are working towards a future where late-stage diseases are a rarity by developing products to help detect them at their earliest stages.

Software purpose-built to increase compliance, increase revenue, and improve patient outcomes.

Our AI-suite of compliance, improvement software and adjunctive aids are designed to solve complex problems with comprehensive solutions across the entire care continuum.

We have developed a state-of-the-art artificial intelligence (AI) suite to improve:

ACT

WRDensity

WRRisk

Using some of the world's largest radiology data sets, our team of experts have developed a suite of AI-powered tools that enable dramatic change across the full testing lifecycle.

“A customer testimonial goes here. A physician or user testimonial goes here. A physician or user testimonial goes here.A physician or user testimonial goes here. A physician or user testimonial goes here. A physician or user testimonial goes here.”— Attribution

Our products have made an impact at more than 300 breast health centers across the country.

ACT has driven a20% improvement in compliance YOY for our largest customer.¹

WRDensity has demonstrated an 82.2% accuracy (BI-RADS A, B, C, D) compared to inter-radiologist agreement at just 67.4%.²

Our Research

We are dedicated to advancing the vanguard of training, validation, and application of AI to benefit patients, radiologists, clinic operators, and payors; take a moment to review some of our work.

Whiterabbit.ai: Why We Invested

RadNet and Whiterabbit.ai Form a Comprehensive Partnership to Address Mammography Compliance and Improved Diagnostics for Breast Cancer

Follow the Whiterabbit: AI developer exits stealth mode with FDA OK for breast cancer screening tool

Stay in touch

Subscribe to our email list to keep up with our work.

Footnotes

“A customer testimonial goes here. A physician or user testimonial goes here. A physician or user testimonial goes here.A physician or user testimonial goes here. A physician or user testimonial goes here. A physician or user testimonial goes here.”

— Attribution

ACT has driven a
20% improvement in compliance YOY for our largest customer.¹